ZHONGHENG GROUP(SH:600252) Xin Lang Cai Jing·2025-12-19 03:12Group 1 - The core viewpoint of the news is that Zhongheng Group's stock has shown a positive trend with a year-to-date increase of 15.04%, despite a slight decline over the past 60 days [1] - As of December 19, Zhongheng Group's stock price reached 2.83 CNY per share, with a market capitalization of 9.042 billion CNY [1] - The company experienced a net inflow of main funds amounting to 1.4547 million CNY, with significant buying and selling activities recorded [1] Group 2 - Zhongheng Group, established on July 28, 1993, is primarily engaged in investments and management in various sectors including pharmaceuticals, energy, and real estate [2] - The company's revenue composition includes 66.19% from pharmaceutical sales, 19.21% from food sales, and 5.58% from daily chemical products [2] - As of September 30, 2025, Zhongheng Group reported a revenue of 1.948 billion CNY, reflecting a year-on-year growth of 1.10%, and a net profit of 24.64 million CNY, which is a significant increase of 119.61% [2] Group 3 - Zhongheng Group has distributed a total of 2.941 billion CNY in dividends since its A-share listing, with 68.74 million CNY distributed over the past three years [3] - As of September 30, 2025, the top ten circulating shareholders include various ETFs, with notable changes in holdings among major shareholders [3]